Aggressive cancer treatment and its role in predisposing to infection.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000380:Agranulocytosis / Q000150:complications; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D003428:Cross Infection; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D017053:Infection Control; D007239:Infections / Q000209:etiology*; D012157:Mononuclear Phagocyte System / Q000187:drug effects; D009092:Mucous Membrane / Q000187:drug effects; D009369:Neoplasms / Q000150:complications / Q000276:immunology / Q000628:therapy*; D010585:Phagocyte Bactericidal Dysfunction / Q000139:chemically induced / Q000150:complications
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents